1335059-09-0

Basic information

• Product Name: 5-bromo-3-cyclopropylpyridin-2-amine
• CAS NO: 1335059-09-0
• Molecular Weight: 213.077
• Mol File: 1335059-09-0.mol

Chemical Properties

• Boiling Point: 256.2±40.0 °C(Predicted)
• Density: 1.650±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 5-bromo-3-cyclopropylpyridin-2-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-bromo-3-cyclopropylpyridin-2-amine(1335059-09-0)
• EPA Substance Registry System: 5-bromo-3-cyclopropylpyridin-2-amine(1335059-09-0)

Safety Data

• Hazardous Substances Data: 1335059-09-0(Hazardous Substances Data)

Upstream product

• 13534-99-1 2-Amino-3-bromopyridine 
• 878805-25-5 2-amino-3-cyclopropylpyridine 

Downstream Products

• 1620575-00-9 3-cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine 

Relevant articles and documents

TRICYCLIC DLK INHIBITORS AND USES THEREOF

The invention relates to compounds of formula (I) and salts thereof, wherein ring A and R1-R2 have any of the values defined in the specification. The compounds and salts are useful for treating DLK mediated disorders. The invention also provides pharmaceutical compositions comprising a compound of formula (I), or a pharmaceutically acceptable salt thereof, as well as methods of using said compounds, salts, or compositions as DLK inhibitors and for treating neurodegeneration diseases and disorders.

3-SUBSTITUTED PYRAZOLES AND USE AS DLK INHIBITORS

The present invention provides for compounds of Formula (I) and various embodiments thereof, and compositions comprising compounds of Formula (I) and various embodiments thereof. (I) In compounds of Formula I, the groups R1, R2, R3, R4, R5, R6 and R7 have the meaning as described herein. The present invention also provides for methods of using compounds of Formula I and compositions comprising compounds of Formula (I) as DLK inhibitors and for treating neurodegeneration diseases and disorders.